Literature DB >> 16238482

Clinical elements that predict outcome after traumatic brain injury: a prospective multicenter recursive partitioning (decision-tree) analysis.

Allen W Brown1, James F Malec, Robyn L McClelland, Nancy N Diehl, Jeffrey Englander, David X Cifu.   

Abstract

Traumatic brain injury (TBI) often presents clinicians with a complex combination of clinical elements that can confound treatment and make outcome prediction challenging. Predictive models have commonly used acute physiological variables and gross clinical measures to predict mortality and basic outcome endpoints. The primary goal of this study was to consider all clinical elements available concerning a survivor of TBI admitted for inpatient rehabilitation, and identify those factors that predict disability, need for supervision, and productive activity one year after injury. The Traumatic Brain Injury Model Systems (TBIMS) database was used for decision tree analysis using recursive partitioning (n = 3463). Outcome measures included the Functional Independence Measure(), the Disability Rating Scale, the Supervision Rating Scale, and a measure of productive activity. Predictor variables included all physical examination elements, measures of injury severity (initial Glasgow Coma Scale score, duration of post-traumatic amnesia [PTA], length of coma, CT scan pathology), gender, age, and years of education. The duration of PTA, age, and most elements of the physical examination were predictive of early disability. The duration of PTA alone was selected to predict late disability and independent living. The duration of PTA, age, sitting balance, and limb strength were selected to predict productive activity at 1 year. The duration of PTA was the best predictor of outcome selected in this model for all endpoints and elements of the physical examination provided additional predictive value. Valid and reliable measures of PTA and physical impairment after TBI are important for accurate outcome prediction.

Entities:  

Mesh:

Year:  2005        PMID: 16238482     DOI: 10.1089/neu.2005.22.1040

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  31 in total

1.  Project VALOR: design and methods of a longitudinal registry of post-traumatic stress disorder (PTSD) in combat-exposed veterans in the Afghanistan and Iraqi military theaters of operations.

Authors:  Raymond C Rosen; Brian P Marx; Nancy N Maserejian; Darren W Holowka; Margaret A Gates; Lynn A Sleeper; Jennifer J Vasterling; Han K Kang; Terence M Keane
Journal:  Int J Methods Psychiatr Res       Date:  2011-11-16       Impact factor: 4.035

2.  A clinical decision rule to predict adult patients with traumatic intracranial haemorrhage who do not require intensive care unit admission.

Authors:  Daniel K Nishijima; Kiarash Shahlaie; Angela Echeverri; James F Holmes
Journal:  Injury       Date:  2011-08-11       Impact factor: 2.586

3.  Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.

Authors:  Martina Santarsieri; Christian Niyonkuru; Emily H McCullough; Julie A Dobos; C Edward Dixon; Sarah L Berga; Amy K Wagner
Journal:  J Neurotrauma       Date:  2014-02-06       Impact factor: 5.269

4.  Predicting long-term outcome after traumatic brain injury using repeated measurements of Glasgow Coma Scale and data mining methods.

Authors:  Hsueh-Yi Lu; Tzu-Chi Li; Yong-Kwang Tu; Jui-Chang Tsai; Hong-Shiee Lai; Lu-Ting Kuo
Journal:  J Med Syst       Date:  2015-01-31       Impact factor: 4.460

5.  Response to Foks et al. (doi: 10.1089/neu.2018.5979): Why Our Long-Term Functional Prognosis Tools are a Valuable Contribution to the Traumatic Brain Injury Outcome Literature.

Authors:  William C Walker; Adam P Sima; Jeanne M Hoffman; Cynthia Harrison-Felix; Amma A Agyemang; Katharine A Stromberg; Jennifer H Marwitz; Allen W Brown; Kristin M Graham; Randall Merchant; Jeffrey S Kreutzer
Journal:  J Neurotrauma       Date:  2018-12-04       Impact factor: 5.269

6.  Traumatic Microbleeds in the Hippocampus and Corpus Callosum Predict Duration of Posttraumatic Amnesia.

Authors:  Nicole L Mazwi; Saef Izzy; Can Ozan Tan; Sergi Martinez; Mel B Glenn; Joseph T Giacino; Ona Wu; Ross Zafonte; Brian L Edlow
Journal:  J Head Trauma Rehabil       Date:  2019 Nov/Dec       Impact factor: 2.710

7.  Longitudinal description of the glasgow outcome scale-extended for individuals in the traumatic brain injury model systems national database: a National Institute on Disability and Rehabilitation Research traumatic brain injury model systems study.

Authors:  Christopher R Pretz; Kristen Dams-O'Connor
Journal:  Arch Phys Med Rehabil       Date:  2013-07-06       Impact factor: 3.966

8.  Global Outcome Trajectories After TBI Among Survivors and Nonsurvivors: A National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems Study.

Authors:  Kristen Dams-OʼConnor; Christopher Pretz; Tausif Billah; Flora M Hammond; Cynthia Harrison-Felix
Journal:  J Head Trauma Rehabil       Date:  2015 Jul-Aug       Impact factor: 2.710

9.  COMT Val 158 Met polymorphism is associated with nonverbal cognition following mild traumatic brain injury.

Authors:  Ethan A Winkler; John K Yue; Thomas W McAllister; Nancy R Temkin; Sam S Oh; Esteban G Burchard; Donglei Hu; Adam R Ferguson; Hester F Lingsma; John F Burke; Marco D Sorani; Jonathan Rosand; Esther L Yuh; Jason Barber; Phiroz E Tarapore; Raquel C Gardner; Sourabh Sharma; Gabriela G Satris; Celeste Eng; Ava M Puccio; Kevin K W Wang; Pratik Mukherjee; Alex B Valadka; David O Okonkwo; Ramon Diaz-Arrastia; Geoffrey T Manley
Journal:  Neurogenetics       Date:  2015-11-17       Impact factor: 2.660

10.  The impact of preexisting illness and substance use on functional and neuropsychological outcomes following traumatic brain injury.

Authors:  Marie N Dahdah; Sunni A Barnes; Amy Buros; Andrew Allmon; Rosemary Dubiel; Cynthia Dunklin; Librada Callender; Shahid Shafi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.